首页> 外文OA文献 >Characterization of novel dual tandem CD19/BCMA chimeric antigen receptor T cells to potentially treat multiple myeloma

【2h】

Characterization of novel dual tandem CD19/BCMA chimeric antigen receptor T cells to potentially treat multiple myeloma

机译：新型双串联CD19 / BCMA嵌合抗原受体T细胞的表征潜在地治疗多发性骨髓瘤

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Liqing Kang; Jian Zhang; Minghao Li; Nan Xu; Wei Qi; Jingwen Tan; Xiaoyan Lou; Zhou Yu; Juanjuan Sun; Zhenkun Wang; Chengcheng Fu; Xiaowen Tang; Haiping Dai; Jia Chen; Depei Wu; Lei Yu;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Characterization of novel dual tandem CD19/BCMA chimeric antigen receptor T cells to potentially treat multiple myeloma [J] . Liqing Kang, Jian Zhang, Minghao Li, Biomarker Research . 2020,第1期

机译：新型双串联CD19 / BCMA嵌合抗原受体T细胞的表征潜在地治疗多发性骨髓瘤
2. B-Cell Maturation Antigen (BCMA)-Specific Chimeric Antigen Receptor T Cells (CART-BCMA) for Multiple Myeloma (MM): Initial Safety and Efficacy from a Phase I Study [J] . Cohen Adam D., Garfall Alfred L., Stadtmauer Edward A., Blood: The Journal of the American Society of Hematology . 2016,第22期

机译：针对多发性骨髓瘤（MM）的B细胞成熟抗原（BCMA）特异性嵌合抗原受体T细胞（CART-BCMA）：I期研究的初步安全性和有效性
3. Infusion of chimeric antigen receptor T cells against dual targets of CD19 and B-cell maturation antigen for the treatment of refractory multiple myeloma [J] . Fang Tang, Yin Lu, Yongqin Ge, Journal of International Medical Research . 2020,第1期

机译：嵌合抗原受体T细胞对CD19和B细胞成熟抗原的双靶的抑制治疗难治性多发性骨髓瘤
4. CHIMERIC ANTIGEN RECEPTORS FOR THE TREATMENT OF CANINE B CELL MALIGNANCIES [C] . Heather Wilson-Robles Conference of the American College of Veterinary Internal Medicine . 2014

机译：用于治疗犬B细胞恶性肿瘤的嵌合抗原受体
5. Integration Mapping of piggyBac-Mediated CD19 Chimeric Antigen Receptor T Cells Analyzed by Novel Tagmentation-Assisted PCR [D] . Hamada Motoharu, 濱田太立 2019

机译：通过新型标记辅助PCR分析piggyBac介导的CD19嵌合抗原受体T细胞的整合图谱
6. Characterization of novel dual tandem CD19/BCMA chimeric antigen receptor T cells to potentially treat multiple myeloma [O] . Liqing Kang, Jian Zhang, Minghao Li, 2020

机译：新型双串联CD19 / BCMA嵌合抗原受体T细胞的表征可潜在治疗多发性骨髓瘤
7. Characterization of novel dual tandem CD19/BCMA chimeric antigen receptor T cells to potentially treat multiple myeloma [O] . Liqing Kang, Jian Zhang, Minghao Li, 2020

机译：新型双串联CD19 / BCMA嵌合抗原受体T细胞的表征潜在地治疗多发性骨髓瘤

Characterization of novel dual tandem CD19/BCMA chimeric antigen receptor T cells to potentially treat multiple myeloma

著录项

引文网络

相似文献

相关主题

期刊订阅